Serial 98228658
Live / Registered — Registered (as of 07 Jan 2025)
What this means for you
Registered since 07 Jan 2025. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98228658
- Registration number
- 7638907
- Mark type
- Design / logo
- Filed
- 18 Oct 2023
- Published for opposition
- 19 Nov 2024
- Registered
- 07 Jan 2025
- Attorney of record
- Cara M. Kearney
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations and substances for the treatment of amyloidosis
Owner
- AstraZeneca AB, Södertälje, SE
- AstraZeneca AB, Södertälje, SE
- AstraZeneca AB, Södertälje, SE
Prosecution history
- 07 Jan 2025 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 07 Jan 2025 — REGISTERED-PRINCIPAL REGISTER
- 19 Nov 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 19 Nov 2024 — PUBLISHED FOR OPPOSITION
- 13 Nov 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 11 Oct 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 11 Oct 2024 — USE AMENDMENT ACCEPTED
- 02 Aug 2024 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 02 Aug 2024 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 02 Aug 2024 — ASSIGNED TO LIE
- 14 Feb 2024 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 14 Feb 2024 — AMENDMENT TO USE PROCESSING COMPLETE
- 14 Feb 2024 — USE AMENDMENT FILED
- 14 Feb 2024 — TEAS AMENDMENT OF USE RECEIVED
- 10 Jan 2024 — NOTIFICATION OF NON-FINAL ACTION E-MAILED